Absence of interaction between furosemide and mitomycin C

J. Verweij; S. Kerpel-Fronius; M. Stuurman; J. de Vries; H. M. Pinedo

doi:10.1007/BF00296263

Absence of interaction between furosemide and mitomycin C

J. Verweij, S. Kerpel-Fronius, M. Stuurman, J. de Vries, H. M. Pinedo

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The possible interaction between furosemide and mitomycin C (MMC) was studied in five patients. The pharmacokinetics of MMC were studied using an HPLC assay. Furosemide was administered prior to, or 120 min after MMC. Furosemide did not change the pharmacokinetics of MMC, nor did it change the amount of MMC excreted in the urine. There appears to be no interaction between the two drugs.

Original language	English (US)
Pages (from-to)	84-86
Number of pages	3
Journal	Cancer Chemotherapy and Pharmacology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1007/BF00296263
State	Published - Feb 1987
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Oncology
Cancer Research

Access to Document

10.1007/BF00296263

Cite this

@article{cf0b28286f514dc1b73e1958952b2ec2,

title = "Absence of interaction between furosemide and mitomycin C",

abstract = "The possible interaction between furosemide and mitomycin C (MMC) was studied in five patients. The pharmacokinetics of MMC were studied using an HPLC assay. Furosemide was administered prior to, or 120 min after MMC. Furosemide did not change the pharmacokinetics of MMC, nor did it change the amount of MMC excreted in the urine. There appears to be no interaction between the two drugs.",

author = "J. Verweij and S. Kerpel-Fronius and M. Stuurman and {de Vries}, J. and Pinedo, {H. M.}",

year = "1987",

month = feb,

doi = "10.1007/BF00296263",

language = "English (US)",

volume = "19",

pages = "84--86",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Absence of interaction between furosemide and mitomycin C

AU - Verweij, J.

AU - Kerpel-Fronius, S.

AU - Stuurman, M.

AU - de Vries, J.

AU - Pinedo, H. M.

PY - 1987/2

Y1 - 1987/2

N2 - The possible interaction between furosemide and mitomycin C (MMC) was studied in five patients. The pharmacokinetics of MMC were studied using an HPLC assay. Furosemide was administered prior to, or 120 min after MMC. Furosemide did not change the pharmacokinetics of MMC, nor did it change the amount of MMC excreted in the urine. There appears to be no interaction between the two drugs.

AB - The possible interaction between furosemide and mitomycin C (MMC) was studied in five patients. The pharmacokinetics of MMC were studied using an HPLC assay. Furosemide was administered prior to, or 120 min after MMC. Furosemide did not change the pharmacokinetics of MMC, nor did it change the amount of MMC excreted in the urine. There appears to be no interaction between the two drugs.

UR - http://www.scopus.com/inward/record.url?scp=0023148956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023148956&partnerID=8YFLogxK

U2 - 10.1007/BF00296263

DO - 10.1007/BF00296263

M3 - Article

C2 - 3102096

AN - SCOPUS:0023148956

SN - 0344-5704

VL - 19

SP - 84

EP - 86

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 1

ER -

Absence of interaction between furosemide and mitomycin C

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this